3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
4
Phase 4
2
Phase NA
1
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Breast Neoplasms
372
Neoplasms
263
Prostatic Neoplasms
188
Lung Neoplasms
137
Colorectal Neoplasms
128
Head and Neck Neoplasms
76
Colonic Neoplasms
67
Pancreatic Neoplasms
63
Carcinoma, Non-Small-Cell Lung
63
Carcinoma, Hepatocellular
61
Uterine Cervical Neoplasms
57
Multiple Myeloma
54
Precursor Cell Lymphoblastic Leukemia-Lymphoma
53
Neoplasm Metastasis
51
Leukemia, Myeloid, Acute
50
Brain Neoplasms
48
Liver Neoplasms
44
Rectal Neoplasms
42
Melanoma
42
Motor Activity
41
Lymphoma, Non-Hodgkin
41
Lymphoma
39
Leukemia
38
Pain
37
Ovarian Neoplasms
36
Hodgkin Disease
36
Fatigue
34
Depression
34
Barrett Esophagus
34
Lymphoma, Follicular
33
Interventions
edoxaban
1
apixaban
1
Warfarin
1
Rivaroxaban
1
Fondaparinux
1
Enoxaparin
1
Dalteparin
1
Dabigatran
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Has results
×
Pulmonary Embolism
×
Clear all
NCT02744092
2023-10-03
CANVAS
Alliance Foundation Trials, LLC.
Phase NA
Completed
811 enrolled
19 charts